The U.S. Food and Drug Administration (FDA) has launched a new pilot program that aims to streamline medical device development, increase predictability and reduce the time from concept to commercialization.

While the Biden administration and federal agencies have made price transparency a long-term goal for the U.S. healthcare industry, a recent study revealed Americans aren’t actually shopping around very often for better healthcare prices.

Dense breast experts Wendie Berg, MD, and JoAnn Pushkin, executive director of DenseBreast-info Inc., explain the current status of breast density patient inform laws, reimbursement and new technologies to aid cancer detection. 

According to the agency, directories can serve as important resources for patients who need to locate providers or compare health plan networks.

"By imposing a 35%-42% cut, [CMS] has essentially created a scenario where it is going to destroy electrophysiology as a field," explained Dhanunjaya "DJ" Lakkireddy, MD.

We spoke to executives from some of healthcare's most prominent vendors to find out what challenges are on their radar in 2022 and beyond. 

Three major healthcare groups are taking a stand against threats of violence over gender-affirming care by asking the Department of Justice to get involved. 

The American Hospital Association (AHA) has claimed victory after the U.S. District Court for the District of Columbia ruled that the Department of Health and Human Services (HHS) must immediately halt payment cuts to the 340B Drug Pricing Program.